
    
      Study Description:

      This is a retrospective review that includes all participants with human immunodeficiency
      virus (HIV) (PWH) affected by Kaposi sarcoma (KS), KSHV-associated multicentric Castleman
      disease, and KSHV associated inflammatory cytokine syndrome enrolled on the tissue
      procurement study (01-C-0038) and other treatment protocols within the HIV/AIDS Malignancy
      Branch at the National Cancer Institute (NCI) from 1/1/2005 to 12/1/2020.

      Objectives:

      To determine the factors that are associated with bone mineral density (BMD) loss in PWH and
      KSHV associated malignancies.

      Study Population:

      All patients seen at the NIH from 1/1/2005 to 12/1/2020.

      Description of Sites/Facilities conducting research:

      This is a single site study initiated by the HIV/AIDS Malignancy Branch at the National
      Cancer Institute

      Study Duration:

      Data abstraction to completion of data analyses will take about 2 years.
    
  